Carregant...

Sequential Therapy with Minocycline and Candesartan Improves Long Term Recovery after Experimental Stroke

BACKGROUND: Minocycline and candesartan have both shown promise as candidate therapeutics in ischemic stroke, with multiple, and somewhat contrasting, molecular mechanisms. Minocycline is an anti-inflammatory, antioxidant and anti-apoptotic agent and a known inhibitor of matrix metalloproteinases (M...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transl Stroke Res
Autors principals: Soliman, Sahar, Ishrat, Tauheed, Fouda, Abdelrahman Y., Patel, Ami, Pillai, Bindu, Fagan, Susan C.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4559761/
https://ncbi.nlm.nih.gov/pubmed/26004281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12975-015-0408-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!